Loading...

Fund Overview

Fund Size

Fund Size

₹232 Cr

Expense Ratio

Expense Ratio

2.38%

ISIN

ISIN

INF03VN01878

Minimum SIP

Minimum SIP

₹500

Exit Load

Exit Load

1.00%

Inception Date

Inception Date

06 Feb 2024

About this fund

This fund has been in existence for 9 months and 23 days, having been launched on 06-Feb-24.
As of 28-Nov-24, it has a Net Asset Value (NAV) of ₹12.94, Assets Under Management (AUM) of 231.99 Crores, and an expense ratio of 2.38%.
  • WhiteOak Capital Pharma and Healthcare Fund Regular Growth has given a CAGR return of 29.38% since inception.
  • The fund's asset allocation comprises around 85.20% in equities, 0.00% in debts, and 14.80% in cash & cash equivalents.
  • You can start investing in WhiteOak Capital Pharma and Healthcare Fund Regular Growth with a SIP of ₹500 or a Lumpsum investment of ₹500.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

Since Inception

+29.38%

(Cat Avg.)

Portfolio Summaryas of 31st October 2024

Equity197.66 Cr85.20%
Others34.33 Cr14.80%

Top Holdings

All Holdings

Equity

Debt & Others

NameType sortAmount sortHoldings sort
Clearing Corporation Of India LtdCash - Repurchase Agreement22.28 Cr9.60%
Sun Pharmaceuticals Industries LtdEquity22.22 Cr9.58%
Cipla LtdEquity12.83 Cr5.53%
Max Healthcare Institute Ltd Ordinary SharesEquity11.85 Cr5.11%
Poly Medicure LtdEquity8.34 Cr3.59%
Aurobindo Pharma LtdEquity8.1 Cr3.49%
Mankind Pharma LtdEquity7.61 Cr3.28%
Lupin LtdEquity7.47 Cr3.22%
Divi's Laboratories LtdEquity6.2 Cr2.67%
Krishna Institute of Medical Sciences LtdEquity6.1 Cr2.63%
Piramal Pharma LtdEquity6.02 Cr2.60%
Ipca Laboratories LtdEquity5.95 Cr2.56%
Glenmark Pharmaceuticals LtdEquity5.91 Cr2.55%
Dr Reddy's Laboratories LtdEquity5.63 Cr2.43%
Strides Pharma Science LtdEquity4.99 Cr2.15%
Ajanta Pharma LtdEquity4.82 Cr2.08%
Apollo Hospitals Enterprise LtdEquity4.8 Cr2.07%
Neuland Laboratories LimitedEquity4.76 Cr2.05%
Vijaya Diagnostic Centre LtdEquity4.52 Cr1.95%
Fortis Healthcare LtdEquity4.28 Cr1.84%
Net Receivables / (Payables)Cash4.01 Cr1.73%
Torrent Pharmaceuticals LtdEquity3.52 Cr1.52%
Ami Organics LtdEquity3.21 Cr1.38%
Global Health LtdEquity3.14 Cr1.35%
Aster DM Healthcare Ltd Ordinary SharesEquity3.06 Cr1.32%
Rainbow Childrens Medicare LtdEquity3.06 Cr1.32%
91 DTB 03012025Bond - Gov't/Treasury2.97 Cr1.28%
Jupiter Life Line Hospitals LtdEquity2.93 Cr1.27%
Supriya Lifescience LtdEquity2.89 Cr1.25%
Shaily Engineering Plastics LtdEquity2.45 Cr1.06%
Thyrocare Technologies LtdEquity2.43 Cr1.05%
Gufic Biosciences LtdEquity2.35 Cr1.01%
PB Fintech LtdEquity2.31 Cr1.00%
Alkem Laboratories LtdEquity2.27 Cr0.98%
Shilpa Medicare LtdEquity2.19 Cr0.94%
Eris Lifesciences Ltd Registered ShsEquity2.17 Cr0.94%
RPG Life Sciences LtdEquity2.13 Cr0.92%
AstraZeneca Pharma India LtdEquity2.11 Cr0.91%
HealthCare Global Enterprises LtdEquity2.08 Cr0.90%
Kovai Medical Center & Hospital LtdEquity2.04 Cr0.88%
91 DTB 21112024Bond - Gov't/Treasury1.99 Cr0.86%
Blue Jet Healthcare LtdEquity1.85 Cr0.80%
Alembic Pharmaceuticals LtdEquity1.85 Cr0.80%
Laurus Labs LtdEquity1.83 Cr0.79%
182 DTB 12122024Bond - Gov't/Treasury1.69 Cr0.73%
Jubilant Pharmova LtdEquity1.38 Cr0.60%
Suven Pharmaceuticals LtdEquity1.13 Cr0.49%
Gland Pharma LtdEquity0.84 Cr0.36%
191 DTB 12/12/2024Bond - Gov't/Treasury0.6 Cr0.26%
364 DTB 12122024Bond - Gov't/Treasury0.4 Cr0.17%
182 DTB 05122024Bond - Gov't/Treasury0.3 Cr0.13%
364 DTB 09012025Bond - Gov't/Treasury0.1 Cr0.04%

Allocation By Market Cap (Equity)

Large Cap Stocks

27.07%

Mid Cap Stocks

24.55%

Small Cap Stocks

31.53%

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

SectorAmount sortHoldings sort
Healthcare184.92 Cr79.71%
Basic Materials5.67 Cr2.44%
Financial Services2.31 Cr1.00%

Risk & Performance Ratios

Standard Deviation

This fund

--

Cat. avg.

15.67%

Lower the better

Sharpe Ratio

This fund

--

Cat. avg.

0.91

Higher the better

Sortino Ratio

This fund

--

Cat. avg.

1.69

Higher the better

Fund Managers

Piyush Baranwal

Piyush Baranwal

Since February 2024

Ramesh Mantri

Ramesh Mantri

Since February 2024

DP

Dheeresh Pathak

Since February 2024

NS

Naitik Shah

Since April 2024

Additional Scheme Detailsas of 31st October 2024

ISIN
INF03VN01878
Expense Ratio
2.38%
Exit Load
1.00%
Fund Size
₹232 Cr
Age
9 months
Lumpsum Minimum
₹500
Fund Status
Open Ended Investment Company
Benchmark
BSE Healthcare TR INR

Investment ObjectiveInvestment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

iconCapital Gains Taxation:

iconDividend Taxation:

info icon

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund nameExpense RatioExit LoadFund size
1Y
Motilal Oswal S&P BSE Healthcare ETF

Very High Risk

0.2%-₹28.64 Cr44.6%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

Very High Risk

0.9%1.0%₹881.52 Cr38.2%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth

Very High Risk

2.3%1.0%₹881.52 Cr36.2%
Aditya Birla Sun Life Nifty Healthcare ETF

Very High Risk

0.2%-₹40.84 Cr39.2%
ITI Pharma and Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹208.21 Cr47.8%
ITI Pharma and Healthcare Fund Regular Growth

Very High Risk

2.4%1.0%₹208.21 Cr45.0%
Mirae Asset Healthcare Fund Direct Growth

Very High Risk

0.5%1.0%₹2770.21 Cr40.7%
Mirae Asset Healthcare Fund Regular Growth

Very High Risk

1.9%1.0%₹2770.21 Cr38.6%
Nippon India Nifty Pharma ETF

Very High Risk

0.2%-₹852.28 Cr37.1%
Axis NIFTY Healthcare ETF

Very High Risk

0.3%-₹19.81 Cr38.2%

Risk Level

Your principal amount will be at Very High Risk

Very High Risk
Wealth Monitor

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

The NAV of WhiteOak Capital Pharma and Healthcare Fund Regular Growth, as of 28-Nov-2024, is ₹12.94.
The fund's allocation of assets is distributed as 85.20% in equities, 0.00% in bonds, and 14.80% in cash and cash equivalents.
The fund managers responsible for WhiteOak Capital Pharma and Healthcare Fund Regular Growth are:-
  1. Piyush Baranwal
  2. Ramesh Mantri
  3. Dheeresh Pathak
  4. Naitik Shah